Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Greenberg

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Vaccine|July 15, 2019
Randomized study of immune responses to two Tdap vaccines among adolescents primed with DTaP and comparison with results among adolescents primed with DTwPMichael D Decker, David P Greenberg, David R Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 20, 2013
Reduced risk of pertussis in whole-cell compared to acellular vaccine recipients is not supported when data are stratified by agePhilippe André, David R Johnson, David P Greenberg, et al.
Digestive Diseases and Sciences|March 3, 2004
Clostridium difficile colitis in children with cystic fibrosisSunny Zaheed Hussain, Cathy Chu, David P Greenberg, et al.
Human Vaccines & Immunotherapeutics|July 13, 2017
Safety and immunogenicity of a quadrivalent influenza vaccine in adults 65 y of age and olderDavid P Greenberg, Corwin A Robertson, H Keipp Talbot, et al.
The Pediatric Infectious Disease Journal|June 12, 2003
Treatment of children with congenital cytomegalovirus infection with ganciclovirMarian G Michaels, David P Greenberg, Diane L Sabo, et al.
Vaccine|March 26, 2018
Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USAVitali Pool, Antigona Tomovici, David R Johnson, et al.
The Journal of Infectious Diseases|August 27, 2014
Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccineMichael D Decker, Phillip Hosbach, David R Johnson, et al.
Pediatrics|January 2, 2009
Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trialFernando A Guerra, Mark M Blatter, David P Greenberg, et al.
Vaccine|July 12, 2008
Current issues in adolescent immunizationLoretta Brabin, David P Greenberg, Luc Hessel, et al.
The Pediatric Infectious Disease Journal|August 23, 2002
Safety and immunogenicity of a combination diphtheria-tetanus toxoids-acellular pertussis-hepatitis B vaccine administered at two, four and six months of age compared with monovalent hepatitis B vaccine administered at birth, one month and six months of ageDavid P Greenberg, Victor K Wong, Susan Partridge, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Vaccine|July 15, 2019
Randomized study of immune responses to two Tdap vaccines among adolescents primed with DTaP and comparison with results among adolescents primed with DTwPMichael D Decker, David P Greenberg, David R Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 20, 2013
Reduced risk of pertussis in whole-cell compared to acellular vaccine recipients is not supported when data are stratified by agePhilippe André, David R Johnson, David P Greenberg, et al.
Digestive Diseases and Sciences|March 3, 2004
Clostridium difficile colitis in children with cystic fibrosisSunny Zaheed Hussain, Cathy Chu, David P Greenberg, et al.
Human Vaccines & Immunotherapeutics|July 13, 2017
Safety and immunogenicity of a quadrivalent influenza vaccine in adults 65 y of age and olderDavid P Greenberg, Corwin A Robertson, H Keipp Talbot, et al.
The Pediatric Infectious Disease Journal|June 12, 2003
Treatment of children with congenital cytomegalovirus infection with ganciclovirMarian G Michaels, David P Greenberg, Diane L Sabo, et al.
Vaccine|March 26, 2018
Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USAVitali Pool, Antigona Tomovici, David R Johnson, et al.
The Journal of Infectious Diseases|August 27, 2014
Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccineMichael D Decker, Phillip Hosbach, David R Johnson, et al.
Pediatrics|January 2, 2009
Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trialFernando A Guerra, Mark M Blatter, David P Greenberg, et al.
Vaccine|July 12, 2008
Current issues in adolescent immunizationLoretta Brabin, David P Greenberg, Luc Hessel, et al.
The Pediatric Infectious Disease Journal|August 23, 2002
Safety and immunogenicity of a combination diphtheria-tetanus toxoids-acellular pertussis-hepatitis B vaccine administered at two, four and six months of age compared with monovalent hepatitis B vaccine administered at birth, one month and six months of ageDavid P Greenberg, Victor K Wong, Susan Partridge, et al.
Pageof 7